HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R G Schoemaker Selected Research

mozavaptan

7/2001Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
7/2000[Arg8]-vasopressin-induced responses on coronary and mesenteric arteries of rats with myocardial infarction: the effects of V1a- and V2-receptor antagonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R G Schoemaker Research Topics

Disease

6Myocardial Infarction
01/2021 - 05/2000
5Heart Failure
10/2008 - 05/2000
2Inflammation (Inflammations)
01/2021 - 10/2011
2Right Ventricular Hypertrophy
09/2005 - 11/2000
2Infarction (Infarctions)
11/2000 - 07/2000
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Neuroinflammatory Diseases
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
05/2015
1Emphysema
10/2011
1Pneumonia (Pneumonitis)
10/2011
1Chronic Obstructive Pulmonary Disease (COPD)
10/2011
1Airway Remodeling
10/2011
1Renal Insufficiency (Renal Failure)
05/2009
1Pulmonary Arterial Hypertension
01/2008
1Pulmonary Hypertension
09/2005
1Bacterial Infections (Bacterial Infection)
09/2004
1Cicatrix (Scar)
12/2001
1Body Weight (Weight, Body)
05/2000
1Tachycardia (Tachyarrhythmias)
05/2000

Drug/Important Bio-Agent (IBA)

3CollagenIBA
10/2011 - 05/2000
3salicylhydroxamic acid (SHAM)IBA
05/2009 - 05/2000
2MonocrotalineIBA
09/2005 - 11/2000
2relcovaptanIBA
07/2001 - 07/2000
2mozavaptanIBA
07/2001 - 07/2000
2Vasopressins (Vasopressin)IBA
07/2001 - 07/2000
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2021
1Etanercept (Enbrel)FDA Link
01/2021
1Lipocalin-2IBA
05/2015
1Biological ProductsIBA
05/2015
1Tiotropium Bromide (Spiriva)FDA Link
10/2011
1Acetylcholine (Acetylcholine Chloride)FDA Link
10/2011
1Cholinergic Agents (Cholinergics)IBA
10/2011
1ErythropoietinFDA Link
01/2008
1AngiotensinsIBA
12/2001
1Antidiuretic AgentsIBA
07/2001
1Vasoconstrictor AgentsIBA
07/2001
1Arginine Vasopressin (Argipressin)IBA
07/2001
1Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2000
1ImidazolinesIBA
05/2000
1moxonidine (Moxon)IBA
05/2000

Therapy/Procedure

3Ligation
12/2001 - 05/2000
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2008 - 09/2008
1Nephrectomy
05/2009
1Therapeutics
10/2008
1Intravenous Administration
09/2004